Horizon Pharma plc Announces "UCD in Common" for the Urea Cycle Disorder (UCD) Community
Mar 16, 2017 13:30 pm UTC| Business
DUBLIN, Ireland, March 16, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Mar 16, 2017 13:15 pm UTC| Business
MENLO PARK, Calif., March 16, 2017 -- Landec Corporation (NASDAQ:LNDC), a leading innovator of diversified health and wellness solutions within the packaged natural food and biomaterial markets, announced that Debbie...
ING 2016 Integrated Annual Report: Accelerate
Mar 16, 2017 13:05 pm UTC| Business
"Accelerate" is the theme of the 2016 Integrated Annual Report of ING Groep N.V. (IAR) that is published today, together with the Annual Report of ING Bank N.V.. The theme reflects the accelerating pace of change in...
join.me Announces New Integration Within Google’s G Suite Marketplace
Mar 16, 2017 13:01 pm UTC| Business
BOSTON, March 16, 2017 -- LogMeIn, Inc.(NASDAQ:LOGM)todayannouncedjoin.me, is now available as apart of G Suite Marketplace. This new integration brings join.me’s unlimited audio, screen sharing and video...
join.me Announces New Integration Within Google’s G Suite Marketplace
Mar 16, 2017 13:01 pm UTC| Business
BOSTON, March 16, 2017 -- LogMeIn, Inc.(NASDAQ:LOGM)todayannouncedjoin.me, is now available as apart of G Suite Marketplace. This new integration brings join.me’s unlimited audio, screen sharing and video...
Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting
Mar 16, 2017 13:01 pm UTC| Business
CANTON, Mass., March 16, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present data on Xtampza® ER, an extended-release oral formulation of oxycodone with abuse-deterrent properties,...
Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting
Mar 16, 2017 13:01 pm UTC| Business
CANTON, Mass., March 16, 2017 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present data on Xtampza® ER, an extended-release oral formulation of oxycodone with abuse-deterrent properties,...
Supreme Court Showdown: Trump's Sweeping Tariffs on the Brink of Landmark Ruling